MARISSA MARTI-SMITH: Open Payments
NPI 1992273833 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,833 in 48 payments from 9 companies in 2025. Trend: 2023 $798 · 2024 $13,693 · 2025 $11,833
Speaker / faculty: $7,800Travel & lodging: $3,013Food & beverage: $1,020
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 32 | $11,456 |
| AstraZeneca Pharmaceuticals LP | 7 | $145 |
| Novartis Pharmaceuticals Corporation | 2 | $67 |
| Daiichi Sankyo Inc. | 2 | $54 |
| PFIZER INC. | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Immunocore Limited | 1 | $21 |
| Genentech USA, Inc. | 1 | $16 |
| Tempus AI, Inc | 1 | $15 |
Products named: Orserdu, ENHERTU, PLUVICTO, KISQALI, IMFINZI, IBRANCE, Nubeqa, KIMMTRAK.
Industry payments across TX — which companies pay providers there.
